Abstract
Tofacitinib is an oral inhibitor of janus kinases, which is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative co......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
